John Öhd

John Öhd currently works at Modus Therapeutics AB, as Chief Executive Officer, Modus Therapeutics Holding AB, as Chief Executive Officer from 2020, BOOST Pharma ApS, as Director from 2024, AnaCardio AB, as Director, Umecrine Cognition AB, as Director from 2020, SVF Vaccines AB, as Director from 2020, and KDventures AB, as Chief Scientific Officer & Venture Partner.
Dr. Öhd also formerly worked at Shire Sweden AB, as Senior Director-Experimental Medicine, AstraZeneca AB, as Group Director-Development from 2007 to 2012, and Medivir AB, as Chief Medical Officer from 2017 to 2018.
Dr. Öhd received his doctorate degree from the University of Linköping and doctorate degree from the University of Lund.